127 related articles for article (PubMed ID: 2987166)
1. Measurement of WR-2721, WR-1065, and WR-33278 in plasma.
Fahey RC; Newton GL
Int J Radiat Oncol Biol Phys; 1985 Jun; 11(6):1193-7. PubMed ID: 2987166
[TBL] [Abstract][Full Text] [Related]
2. A method for the combined measurement of ethiofos and WR-1065 in plasma: application to pharmacokinetic experiments with ethiofos and its metabolites.
Swynnerton NF; Huelle BK; Mangold DJ; Ludden TM
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1495-9. PubMed ID: 3019967
[TBL] [Abstract][Full Text] [Related]
3. An improved HPLC assay for S-2-(3-aminopropylamino)ethyl phosphorothioate (WR-2721) in plasma.
Swynnerton NF; McGovern EP; Niño JA; Mangold DJ
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1521-4. PubMed ID: 6090354
[TBL] [Abstract][Full Text] [Related]
4. Analysis of S-35 labeled WR-2721 and its metabolites in biological fluids.
Anderson KW; Krohn KA; Grunbaum Z; Phillips RB; Mahler PA; Menard TW; Spence AM; Rasey JS
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1511-5. PubMed ID: 6090353
[TBL] [Abstract][Full Text] [Related]
5. High-performance liquid chromatographic assay using electrochemical detection for the combined measurement of amifostine, WR 1065 and the disulfides in plasma.
Korst AE; Vermorken JB; van der Vijgh WJ
J Chromatogr B Biomed Sci Appl; 1997 May; 693(1):167-74. PubMed ID: 9200531
[TBL] [Abstract][Full Text] [Related]
6. Effect of the radioprotective drugs MEA, DMSO, and WR-2721 on tumor control and skin tolerance in the rat.
Moulder JE; Lo PS; Fischer JJ
Cancer Treat Rep; 1977 Aug; 61(5):825-33. PubMed ID: 196752
[TBL] [Abstract][Full Text] [Related]
7. Alkaline phosphatase promotes radioprotection and accumulation of WR-1065 in V79-171 cells incubated in medium containing WR-2721.
Calabro-Jones PM; Fahey RC; Smoluk GD; Ward JF
Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Jan; 47(1):23-7. PubMed ID: 2982751
[TBL] [Abstract][Full Text] [Related]
8. HPLC assay for 2-(3-aminopropylamino)ethanethiol (WR-1065) in plasma.
McGovern EP; Swynnerton NF; Steele PD; Mangold DJ
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1517-20. PubMed ID: 6480444
[TBL] [Abstract][Full Text] [Related]
9. Modification of WR-2721 toxicity and radioprotection by an inhibitor of alkaline phosphatase.
Brown DQ; Shaw LM; Pittock JW; Mann DJ; Hardiman J; Pogach R; Gold J
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1491-3. PubMed ID: 3019966
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a method for measuring the radioprotective metabolite WR-1065 in plasma using chemical derivatization combined with UHPLC-MS/MS.
Simon ES; Reyna D; Lister RJ; Harteg C; Lipka E
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Mar; 1080():82-89. PubMed ID: 29482122
[TBL] [Abstract][Full Text] [Related]
11. Measurement of WR-1065 in plasma: preliminary pharmacokinetics in the beagle.
Swynnerton NF; Huelle BK; McGovern EP; Mangold DJ; Ludden TM
Res Commun Chem Pathol Pharmacol; 1986 Nov; 54(2):255-69. PubMed ID: 3786948
[TBL] [Abstract][Full Text] [Related]
12. Measurement of both protein-bound and total S-2-(3-aminopropylamino)ethanethiol (WR-1065) in blood by high-performance liquid chromatography.
Bonner HS; Shaw LM
J Chromatogr B Biomed Sci Appl; 2000 Mar; 739(2):357-62. PubMed ID: 10755379
[TBL] [Abstract][Full Text] [Related]
13. Radioprotection of cells in culture by WR-2721 and derivatives: form of the drug responsible for protection.
Smoluk GD; Fahey RC; Calabro-Jones PM; Aguilera JA; Ward JF
Cancer Res; 1988 Jul; 48(13):3641-7. PubMed ID: 2837320
[TBL] [Abstract][Full Text] [Related]
14. Human pharmacokinetics of WR-2721.
Shaw LM; Turrisi AT; Glover DJ; Bonner HS; Norfleet AL; Weiler C; Kligerman MM
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1501-4. PubMed ID: 3019968
[TBL] [Abstract][Full Text] [Related]
15. Determination of the cytoprotective agent WR-2721 (Amifostine, Ethyol) and its metabolites in human blood using monobromobimane fluorescent labeling and high-performance liquid chromatography.
Souid AK; Newton GL; Dubowy RL; Fahey RC; Bernstein ML
Cancer Chemother Pharmacol; 1998; 42(5):400-6. PubMed ID: 9771955
[TBL] [Abstract][Full Text] [Related]
16. Blood thiols following amifostine and mesna infusions, a pediatric oncology group study.
Souid AK; Fahey RC; Aktas MK; Sayin OA; Karjoo S; Newton GL; Sadowitz PD; Dubowy RL; Bernstein ML
Drug Metab Dispos; 2001 Nov; 29(11):1460-6. PubMed ID: 11602522
[TBL] [Abstract][Full Text] [Related]
17. Interaction of amifostine and ionizing radiation on transcriptional patterns of apoptotic genes expressed in human microvascular endothelial cells (HMEC).
Khodarev NN; Kataoka Y; Murley JS; Weichselbaum RR; Grdina DJ
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):553-63. PubMed ID: 15380592
[TBL] [Abstract][Full Text] [Related]
18. Opposite effects of WR-2721 and WR-1065 on radiation-induced hypothermia: possible correlation with oxygen uptake.
Kandasamy SB; Kumar KS; Hunt WA; Weiss JF
Radiat Res; 1988 May; 114(2):240-7. PubMed ID: 2836882
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of WR-1065 in mouse tissue following treatment with WR-2721.
Utley JF; Seaver N; Newton GL; Fahey RC
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1525-8. PubMed ID: 6090355
[TBL] [Abstract][Full Text] [Related]
20. Tissue levels of WR-1065, the active metabolite of amifostine (Ethyol), are equivalent following intravenous or subcutaneous administration in cynomolgus monkeys.
Bachy CM; Fazenbaker CA; Kifle G; McCarthy MP; Cassatt DR
Oncology; 2004; 67(3-4):187-93. PubMed ID: 15557777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
